[Nateglinide]

Nihon Rinsho. 2002 Sep:60 Suppl 9:371-5.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Cyclohexanes / adverse effects
  • Cyclohexanes / pharmacokinetics
  • Cyclohexanes / pharmacology
  • Cyclohexanes / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Drug Therapy, Combination
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemia / chemically induced
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / pharmacokinetics
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / metabolism
  • Insulin Secretion
  • Nateglinide
  • Phenylalanine / adverse effects
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / pharmacokinetics
  • Phenylalanine / pharmacology
  • Phenylalanine / therapeutic use*

Substances

  • Blood Glucose
  • Cyclohexanes
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Nateglinide
  • Phenylalanine